Lee F. Peng, MD, PhD, has been appointed Chief of the Sub-Section of Hepatology, Section of Gastroenterology at Temple University Hospital.
Dr. Peng specializes in liver disease and gastrointestinal endoscopy, including esophagogastroduodenoscopy (EGD) and colonoscopy. His specific disease interests include viral hepatitis, fatty liver disease, autoimmune hepatitis, metabolic liver disease, alcoholic liver disease, cirrhosis, cholestatic liver disease, acute liver failure, and liver transplantation. Much of his research centers on Hepatitis C Infection (HCV), including the discovery and characterization of small molecule modulators of the HCV lifecycle, HCV's relationship to host lipid metabolism, methods of altering the infectivity of HCV, and identifying biomarkers that assist in the prediction of outcomes in chronic HCV infection.